Economic Impact of Atrial Fibrillation on Hospitalization Outcomes of Acute Heart Failure in the United States

2021 ◽  
Vol 138 ◽  
pp. 124-127
Author(s):  
Ashraf Abugroun ◽  
Ahmed Taha ◽  
Manar Abdel-Rahman ◽  
Annabelle Santos Volgman
Keyword(s):  
United States ◽  
Heart Failure ◽  
Atrial Fibrillation ◽  
Economic Impact ◽  
Acute Heart Failure ◽  
The United States

scholarly journals AGE-SPECIFIC TRENDS AND OUTCOMES OF PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE IN THE UNITED STATES

2021 ◽  
Vol 77 (18) ◽  
pp. 540
Author(s):  
Ayman Elbadawi ◽  
Alexander Dang ◽  
Islam Elgendy ◽  
Ravi Thakker ◽  
Aiham Albaeni ◽  
...  
Keyword(s):  
United States ◽  
Heart Failure ◽  
Acute Heart Failure ◽  
The United States

scholarly journals Treating acute heart failure in the elderly: A comparison of three inpatient treatment alternatives in the United States

2013 ◽  
Vol 16 (3) ◽  
pp. A9
Author(s):  
A.H. Gradman ◽  
F. Vekeman ◽  
A. Eldar-Lissai ◽  
A. Trahey ◽  
P. Lacomte ◽  
...  
Keyword(s):  
United States ◽  
Heart Failure ◽  
Acute Heart Failure ◽  
Inpatient Treatment ◽  
The Elderly ◽  
The United States ◽  
Treatment Alternatives

Atrial Fibrillation: Epidemiologic Considerations and Rationale for Conversion and Maintenance of Sinus Rhythm

2003 ◽  
Vol 8 (1_suppl) ◽  
pp. S13-S26 ◽  
Author(s):  
Bramah N. Singh
Keyword(s):  
United States ◽  
Heart Failure ◽  
Atrial Fibrillation ◽  
Heart Disease ◽  
Sinus Rhythm ◽  
Surgical Techniques ◽  
Hypertensive Heart Disease ◽  
Fold Increase ◽  
The United States ◽  
Lone Atrial Fibrillation

Atrial fibrillation is now the most common cardiac arrhythmia for which a patient is hospitalized. Clinically, it presents in a form that is paroxysmal, persistent, or permanent and may be symptomatic or asymptomatic, occurring in the setting of either no cardiac disease (“lone atrial fibrillation”) or, most often, in association with an underlying disease. Atrial fibrillation is associated with a 2-fold increase in mortality and, in the United States alone, causes over 75,000 cases of stroke per year. The annual prevalence of stroke is 5% to 7%, but the use of adequate anticoagulation can reduce this to less than 1%. Atrial fibrillation is a disorder of the elderly, with almost equal prevalence in men and women. In the United States, 80% of atrial fibrillation occurs in patients over the age of 65 years, and its prevalence tracks that of heart failure, which may be the cause, as well as the result, of the arrhythmia. Both conditions are increasing in epidemic proportions in the aging population. The most common causes of atrial fibrillation are hypertensive heart disease, coronary artery disease, and heart failure with a miscellany of lesser conditions, with about 10% lacking structural heart disease. Unlike other supraventricular arrhythmias, cure by the use of catheter ablation and surgical techniques has not been a reality except in a relatively small number of cases. However, restoration and maintenance of sinus rhythm remain the initial goal of therapy for most patients. Pharmacologic approaches remain the mainstay of therapy for rate control and anticoagulation as well as for maintenance of sinus rhythm following pharmacological or electrical conversion. The changing epidemiology of atrial fibrillation is highlighted, with the focus on its conversion by the use of newer and novel antifibrillatory agents relative to the mechanisms of the arrhythmia, to restore the stability of sinus rhythm.

Abstract 2157: Racial Differences in Hospitalizations for Atrial Fibrillation in the United States

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Paul B Tabereaux ◽  
Todd M Brown ◽  
Jose Osorio ◽  
G. N Kay ◽  
Dawn M Bravada
Keyword(s):  
Diabetes Mellitus ◽  
United States ◽  
Risk Factors ◽  
Heart Failure ◽  
Atrial Fibrillation ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
The United States ◽  
Principal Diagnosis ◽  
Common Risk Factors

Introduction: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the United States; however a paucity of population-based data about nonwhite individuals exist. The objectives of this study were to compare hospitalizations among Whites and African Americans (AA) and to determine whether race is an independent predictor of hospitalization for AF in the United States. Methods: Data was obtained from the National Hospital Discharge Survey (years 1996 –2005) and included hospitalizations with a principal diagnosis of AF for patients aged ≥18 yrs and race designated as either White or AA. Codes from the International Classification of Diseases -9th revision were used to define AF (427.31), hypertension (401– 405), ischemic heart disease (410 – 414), diabetes mellitus (250), heart failure (425,428) and valvular heart disease (424). Multivariable analysis with logistic regression was used to identify factors that were independently associated with AF hospitalizations Results: Among 297,962,043 hospitalizations between 1996 –2005, 3,676,787 (1.2%) had a principal diagnosis of AF. Among the hospitalizations for AF, white race was more common than AA race (2,393,659/186,904,962 of whites (1.3% of white’s hospitalized) and 209,788/33,972,665 of African Americans (0.6% of AA’s hospitalized), p<0.0001). After adjusting for the most common risk factors for AF (age, sex, hypertension, ischemic heart disease, diabetes mellitus, heart failure and valvular heart disease) AA race was independently associated with a decreased odds of hospitalizations for AF (Table 1 : adjusted OR=0.49, 95%CI 0.46 – 0.51). Conclusions: After adjusting for the most common risk factors for AF, the odds of hospitalization for AF in AA’s remained half that of whites. Race may be a novel and unaccounted risk factor for atrial fibrillation.

Sign in / Sign up

Export Citation Format

Share Document